sitagliptin krka 50 mg tabletti, kalvopäällysteinen
krka, d.d., novo mesto - sitagliptin - tabletti, kalvopäällysteinen - 50 mg - sitagliptiini
sitagliptin krka 100 mg tabletti, kalvopäällysteinen
krka, d.d., novo mesto - sitagliptin - tabletti, kalvopäällysteinen - 100 mg - sitagliptiini
sitagliptin / metformin hydrochloride accord
accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabetes mellitus, tyyppi 2 - diabeetilla käytettävät lääkkeet - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. kolmen lääkkeen yhdistelmähoito) lisänä ruokavalion ja liikunnan ohella potilaille riittävästi hallinnassa heidän maksimaalinen siedetty annos metformiinia ja sulfonyyliureaa. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.
sitagliptin / metformin hydrochloride sun
sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabetes mellitus, tyyppi 2 - diabeetilla käytettävät lääkkeet - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. kolmen lääkkeen yhdistelmähoito) lisänä ruokavalion ja liikunnan ohella potilaille riittävästi hallinnassa heidän maksimaalinen siedetty annos metformiinia ja sulfonyyliureaa. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.
kentera (previously oxybutynin nicobrand)
teva b.v. - oksibutyniini - virtsankarkailua, kiire - urologiset - vaikea inkontinenssin oireeton hoito ja / tai lisääntynyt virtsatiheys ja kiireellisyys, joita voi esiintyä aikuispotilailla, joilla on epästabiili virtsarakon.
atacand plus 8 mg / 12,5 mg tabletti
cheplapharm arzneimittel gmbh - candesartan cilexetil, hydrochlorothiazide - tabletti - 8 mg / 12,5 mg - kandesartaani ja diureetit
atacand plus 16 mg / 12,5 mg tabletti
cheplapharm arzneimittel gmbh - candesartan cilexetil, hydrochlorothiazide - tabletti - 16 mg / 12,5 mg - kandesartaani ja diureetit
teveten comp 600 mg / 12.5 mg tabletti, kalvopäällysteinen
viatris oy - hydrochlorothiazide, eprosartan mesylate - tabletti, kalvopäällysteinen - 600 mg / 12.5 mg - eprosartaani ja diureetit
olmetec plus 20 mg / 12,5 mg tabletti, kalvopäällysteinen
daiichi sankyo europe gmbh - hydrochlorothiazide, olmesartan medoxomil - tabletti, kalvopäällysteinen - 20 mg / 12,5 mg - olmesartaanimedoksomiili ja diureetit
olmetec plus 20 mg / 25 mg tabletti, kalvopäällysteinen
daiichi sankyo europe gmbh - hydrochlorothiazide, olmesartan medoxomil - tabletti, kalvopäällysteinen - 20 mg / 25 mg - olmesartaanimedoksomiili ja diureetit